272 related articles for article (PubMed ID: 17532964)
1. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.
Drakos SG; Stringham JC; Long JW; Gilbert EM; Fuller TC; Campbell BK; Horne BD; Hagan ME; Nelson KE; Lindblom JM; Meldrum PA; Carlson JF; Moore SA; Kfoury AG; Renlund DG
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1612-9. PubMed ID: 17532964
[TBL] [Abstract][Full Text] [Related]
2. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
[TBL] [Abstract][Full Text] [Related]
3. HLA sensitization in ventricular assist device recipients: does type of device make a difference?
Kumpati GS; Cook DJ; Blackstone EH; Rajeswaran J; Abdo AS; Young JB; Starling RC; Smedira NG; McCarthy PM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1800-7. PubMed ID: 15173739
[TBL] [Abstract][Full Text] [Related]
4. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
5. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
[TBL] [Abstract][Full Text] [Related]
6. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
7. Association of device surface and biomaterials with immunologic sensitization after mechanical support.
George I; Colley P; Russo MJ; Martens TP; Burke E; Oz MC; Deng MC; Mancini DM; Naka Y
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1372-9. PubMed ID: 18544389
[TBL] [Abstract][Full Text] [Related]
8. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
[TBL] [Abstract][Full Text] [Related]
10. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
11. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.
Baran DA; Gass AL; Galin ID; Zucker MJ; Arroyo LH; Goldstein DJ; Prendergast T; Lubitz S; Courtney MC; Correa R; Chan M; Spielvogel D; Lansman SL
J Heart Lung Transplant; 2005 Nov; 24(11):1886-90. PubMed ID: 16297796
[TBL] [Abstract][Full Text] [Related]
12. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
13. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
Shuhaiber J; Hur K; Gibbons R
J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
[TBL] [Abstract][Full Text] [Related]
14. Sensitization.
Ogura K
Clin Transpl; 1992; ():357-69. PubMed ID: 1306712
[TBL] [Abstract][Full Text] [Related]
15. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.
Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC
J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859
[TBL] [Abstract][Full Text] [Related]
16. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
[TBL] [Abstract][Full Text] [Related]
17. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.
Joyce DL; Southard RE; Torre-Amione G; Noon GP; Land GA; Loebe M
J Heart Lung Transplant; 2005 Dec; 24(12):2054-9. PubMed ID: 16364849
[TBL] [Abstract][Full Text] [Related]
18. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
[TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
[TBL] [Abstract][Full Text] [Related]
20. Effects of left ventricular assist device therapy on ventricular arrhythmias.
Ziv O; Dizon J; Thosani A; Naka Y; Magnano AR; Garan H
J Am Coll Cardiol; 2005 May; 45(9):1428-34. PubMed ID: 15862414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
